Mirum Pharmaceuticals, Inc. (MIRM): Capital Expenditures
$954.0K
Year ended 2025-12-31
$1.47M
Trailing 12 months to 2026-06-30
+50.8%
3-year compound annual growth
+33.5%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $954.0K | -3.9% | 2026-02-25, From 2025-01-01 |
| 2024-12-31 | $993.0K | +811.0% | 2026-02-25, From 2024-01-01 |
| 2023-12-31 | $109.0K | -60.8% | 2026-02-25, From 2023-01-01 |
| 2022-12-31 | $278.0K | n/m | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | $24.0K | -89.3% | 2024-03-15, From 2021-01-01 |
| 2020-12-31 | $225.0K | -19.9% | 2022-03-09, From 2020-01-01 |
| 2019-12-31 | $281.0K | n/a | 2021-03-09, From 2019-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | 2025-12-31 | $954.0K | -3.9% |
| BridgeBio Pharma, Inc. (BBIO) | 2025-12-31 | $1.10M | +17.6% |
| HUTCHMED (China) Ltd (HCM) | 2025-12-31 | $14.15M | -21.1% |
| Organogenesis Holdings Inc. (ORGO) | 2025-12-31 | $14.15M | +41.1% |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $6.48M | -40.9% |
| Zai Lab Ltd (ZLAB) | 2025-12-31 | $8.10M | +43.2% |
| Insmed Inc (INSM) | 2025-12-31 | $32.56M | +48.5% |
| Opko Health, Inc. (OPK) | 2025-12-31 | $12.28M | -50.9% |
| TG Therapeutics, Inc. (TGTX) | 2025-12-31 | $214.0K | +375.6% |
Compare MIRM, BBIO, HCM, ORGO side by side · Screen every company in Pharmaceutical Preparations ↗